Skip to content

Treatment of Temporomandibular Disorders

Massage and Transcutaneous Electrical Nerve Stimulation Therapies for Temporomandibular Disorders in Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01187316
Enrollment
8
Registered
2010-08-24
Start date
2007-04-30
Completion date
2007-09-30
Last updated
2010-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Joint Disorders

Keywords

Facial Pain, Temporomandibular Joint Disorders, Transcutaneous Electric Nerve Stimulation, Adolescent

Brief summary

The aim of the present study was to carry out a pilot project comparing the effectiveness of two therapeutic approaches to temporomandibular disorders (TMDs) in adolescents. Eight female individuals diagnosed based on the Research Diagnosis Criteria for TMDs (RDC/TMD-axis 1)were randomly divided into two groups: 1) Massage therapy and muscle stretching (n=4); and 2) transcutaneous electrical nerve stimulation (TENS) (n=4). Regardless the treatment, ten sessions were held for each patient and two measurements (baseline and 10th session) were performed for the assessment of symptom evolution using a visual analog scale (VAS), maximum opening of the mouth (MOM) and pressure pain threshold (PPT). Statistical analysis wiil be carefully selected.

Interventions

DEVICETranscutaneous electrical nerve stimulation

Sensors were positioned on anterior temporal and masseter muscles bilaterally, and the stimulation was used for 20 minutes at 150 Hz and 100 µs of pulse width; intensity was adjusted individually.

OTHERPhysiotherapy

Massage and stretching of the anterior temporal and masseter muscle were performed by an experienced professional for 20 minutes.

Sponsors

University of Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Pain in orofacial area for at least 3 months * Diagnosed at group 1 of RDC/TMD (myofascial pain with or without mouth opening limit)

Exclusion criteria

* Drug use for treatment of pain * Functional limitations that would harm diagnosis

Design outcomes

Primary

MeasureTime frameDescription
PainTwo times a weekThe subjects was asked to mark the intensity of the pain on a 100mm line, which was numbered from 0 to 10, being 0 = no pain, and 10 = to the worst pain ever felt. The outcome of pain intensity was given as a number marked by the patient.

Secondary

MeasureTime frameDescription
Maximum mouth opening amplitudeTwo times a weekSubjects were asked to open their mouths as much as they could and the opening amplitude was measured using a digital caliper.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026